Summary
Prescribed doses of drugs for which individualisation of dosage is deemed necessary were recorded from one national and one local Swedish prescription monitoring study for the years 1976, 1982 and 1985. Dose patterns were analysed in order to determine whether the practice of individualising drug doses had become more widely adopted by physicians. Amongst drugs eliminated primarily by metabolism, (propranolol and amitriptyline were prescribed in highly variable doses (30-fold or more). The three commonest doses of these agents accounted for about 60% of the prescriptions. In general, doses decreased with increasing patient age. Prescribing practices for piroxicam differed markedly from those of propranolol and amitriptyline, with one fixed dose of piroxicam accounting for about 90% of all prescriptions.
For drugs eliminated mainly by renal excretion (digoxin, cimetidine and atenolol) there was an 8–10-fold variation in the prescribed doses. The most frequent dose of these drugs accounted for 40–60% of the prescriptions. Doses of cimetidine and atenolol were lowered only in the oldest patients. The doses of digoxin decreased more evenly with increasing age, and were reduced in elderly patients on long-term maintenance therapy. The difference in digoxin dose between young and old patients increased during the study period.
Prescription monitoring as a method for following-up drug usage may be instrumental in evaluating the effect of drug educational efforts.
Similar content being viewed by others
References
Boëthius G, Sjöqvist F (1978) Doses and dosage intervals of drugs — clinical practice and pharmacokinetic principles. Clin Pharmacol Ther 24: 255–263
Boëthius G, Wiman F (1977) Recording of drug prescriptions in the county of Jämtland, Sweden. I. Methodological aspects. Eur J Clin Pharmacol 12: 31–35
Wessling A (1987) Continuous recording of drug prescribing in Sweden 1974–1983. Methods and examples of utilization of data. Eur J Clin Pharmacol 33: 7–13
Routledge PA, Shand DG (1979) Clinical pharmacokinetics of propranolol. Clin Pharmacokinet 4: 73–90
von Bahr C, Collste P, Frisk-Holmberg M, Haglund K, Jorfelt I, Orme M, Östman J, Sjöqvist F (1976) Plasma levels and effects of metoprolol on blood pressure, adrenergic beta receptor blockade, and plasma renin activity in essential hypertension. Clin Pharmacol Ther 20: 130–137
Farmacevtiska specialiteter i Sverige (1976, 1982, 1985) Stockholm, Läkemedelsinformation AB
Sjöqvist F, Bertilsson L (1981) Clinical pharmacology of tricyclic antidepressants. Facts, controversies and future challenges. In: Usdin E (ed) Clinical pharmacology in psychiatry. Elsevier, New York, pp 141–153
Åsberg M (1977) Depressioner. In Läkemedelsboken 77. Apoteksbolaget AB, Stockholm, pp 538–550
Brogden RN, Heel RC, Speight TM, Avery GS (1984) Piroxicam a reappraisal of its pharmacology and therapeutic efficacy. Drugs 28: 292–323
Läkemedelsbiverkningar Meddelande nr 38 (1982) Läkartidningen 79: 3821–3822
O'Malley K, Judge TG, Crooks J (1976) Geriatric clinical pharmacology and therapeutics. In: Avery GS (ed) Drug treatment. Principles and practice of clinical pharmacology and therapeutics. Australasian Drug Information Services Press, Sydney, pp 158–181
Impivaara O, Iisalo E (1985) Serum digoxin concentrations in a representative digoxin-consuming adult population. Eur J Clin Pharmacol 27: 627–632
Bergman U, Sjöqvist F, Söderhielm L (1976) Use of digoxin in a low density population area in Sweden. Eur J Clin Pharmacol 10: 19–24
Redolfi A, Borgogelli E, Lodola E (1979) Blood level of cimetidine in relation to age. Eur J Clin Pharmacol 15: 257–261
Somogyi A, Rohner H-G, Gugler R (1980) Pharmacokinetics and bioavilability of cimetidine in gastric and duodenal ulcer patients. Clin Pharmacokinet 5: 84–94
Drayer DE, Romankiewicz J, Lorenzo B, Reidenberg MM (1982) Age and renal clearance of cimetidine. Clin Pharmacol Ther 31: 45–50
Johansson C (1985) Matstrupe-magsäckssjukdomar. In Läkemedelsboken 85. Apoteksbolaget AB, Stockholm, pp 492–504
McAinsh J, Holmes BF, Smith S, Hood D, Warren D (1980) Atenolol kinetics in renal failure. Clin Pharmacol Ther 28: 302–309
Nies A, Robinson DS, Friedman MJ, Green R, Cooper TB, Ravaris CL, Ives JO (1977) Relationship between age and tricyclic antidepressant plasma levels. Am J Psychiatry 134: 790–793
Castleden CM, George CF (1979) The effect of ageing on the hepatic clearance of propranolol. Br J Clin Pharmacol 7: 49–54
Vestal RE, Wood AJJ, Branch RA, Shand DG, Wilkinson GR (1979) Effects of age and cigarette smoking on propranolol disposition. Clin Pharmacol Ther 26: 8–15
Vestal RE, Alastair JJ, Wood MB, Shand DG (1979) Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther 26: 181–185
Bergman U, Wiholm B-E (1981) Drug-related problems causing admission to a medical clinic. Eur J Clin Pharmacol 20: 193–200
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wessling, A., Boëthius, G. & Sjöqvist, F. Prescription monitoring of drug dosages in the county of Jämtland and Sweden as a whole in 1976, 1982 and 1985. Eur J Clin Pharmacol 38, 329–334 (1990). https://doi.org/10.1007/BF00315570
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00315570